deltatrials
Terminated NA INTERVENTIONAL 4-arm NCT03202498

Safety and Tolerability of Yaq-001 in Patients With Cirrhosis

Safety and Tolerability of Yaq-001 in Patients With Cirrhosis (CARBALIVE-SAFETY)

Sponsor: A2F Associates Limited

Conditions Liver Cirrhosis
Interventions 4g Placebo 4g Yaq-001 8g Placebo 8g Yaq-001
Updated 15 times since 2017 Last updated: Aug 21, 2020 Started: Feb 28, 2019 Primary completion: Mar 26, 2020 Completion: Mar 26, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

COVID-19 pandemic prevents patients from making in-hospital visits, which are mandatory to assessment of safety in this study

A NA clinical study on Liver Cirrhosis, this trial is terminated or withdrawn. The trial is conducted by A2F Associates Limited and has accumulated 15 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jul 2017 – ~Jun 2018 · 11 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Feb 2019 · 7 months · monthly snapshot~Feb 2019 – ~Jun 2019 · 4 months · monthly snapshot~Jun 2019 – ~Aug 2019 · 2 months · monthly snapshot~Aug 2019 – ~Nov 2019 · 3 months · monthly snapshot~Nov 2019 – ~Sep 2020 · 10 months · monthly snapshot~Sep 2020 – ~Nov 2020 · 2 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshot~Oct 2021 – ~Dec 2021 · 2 months · monthly snapshot~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

15 versions recorded

  1. Sep 2025 — Present [monthly]

    Terminated NA

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated NA

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  4. Dec 2021 — Jul 2024 [monthly]

    Terminated NA

  5. Oct 2021 — Dec 2021 [monthly]

    Terminated NA

▶ Show 10 earlier versions

  1. Jan 2021 — Oct 2021 [monthly]

    Terminated NA

  2. Nov 2020 — Jan 2021 [monthly]

    Terminated NA

  3. Sep 2020 — Nov 2020 [monthly]

    Terminated NA

    Status: Recruiting → Terminated

  4. Nov 2019 — Sep 2020 [monthly]

    Recruiting NA

  5. Aug 2019 — Nov 2019 [monthly]

    Recruiting NA

  6. Jun 2019 — Aug 2019 [monthly]

    Recruiting NA

    Status: Not Yet Recruiting → Recruiting

  7. Feb 2019 — Jun 2019 [monthly]

    Not Yet Recruiting NA

  8. Jul 2018 — Feb 2019 [monthly]

    Not Yet Recruiting NA

  9. Jun 2018 — Jul 2018 [monthly]

    Not Yet Recruiting NA

  10. Jul 2017 — Jun 2018 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • A2F Associates Limited
  • Alpha Bioresearch S.L.
  • Assistance Publique - Hôpitaux de Paris
  • Azienda Ospedaliera di Padova
  • Hospital Universitari Vall d'Hebron Research Institute
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna
  • Institut d'Investigacions Biomèdiques August Pi i Sunyer
  • Servicio Madrileño de Salud, Madrid, Spain
  • University College, London
  • University of Bern
  • University of Brighton
  • University of Lisbon
  • Yaqrit Ltd
Data source: Yaqrit Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations